Home » Stocks » HRC

Hill-Rom Holdings, Inc. (HRC)

Stock Price: $99.45 USD -0.61 (-0.61%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
Market Cap 6.60B
Revenue (ttm) 2.88B
Net Income (ttm) 223.00M
Shares Out 66.63M
EPS (ttm) 3.32
PE Ratio 29.95
Forward PE 18.52
Dividend $0.88
Dividend Yield 0.88%
Trading Day January 22
Last Price $99.45
Previous Close $100.06
Change ($) -0.61
Change (%) -0.61%
Day's Open 99.84
Day's Range 99.27 - 100.88
Day's Volume 495,016
52-Week Range 74.34 - 116.99

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 2 days ago

Hill-Rom's (HRC) acquisition of Bardy Diagnostics enables the former to expand into ambulatory cardiac monitoring space to accelerate digital health offering.

PRNewsWire - 4 days ago

CHICAGO, Jan. 19, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced it has reached a definitive agreement to acquire Bardy Diagnostics, Inc. (BardyDx), an innovator in digital health an...

GuruFocus - 6 days ago

The S&P 500 saw its trailing 12-month real earnings per share increase by approximately 1% on average every year over the past five years. The index's share price ($3,768.25 as of Friday) has ...

Other stocks mentioned: LFUS, TCF
Zacks Investment Research - 2 weeks ago

Here we discuss four dividend-paying value stocks, MCK, CAH, BDX and HRC, which though trading cheap now, have solid chances of a rebound in the second half of 2021.

Other stocks mentioned: BDX, CAH, MCK
PRNewsWire - 2 weeks ago

CHICAGO, Jan. 7, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) will host its fiscal first quarter 2021 earnings conference call and webcast on Friday, February 5, 2021, beginning at 7:30 a.m. (CT) ...

Zacks Investment Research - 3 weeks ago

Hill-Rom (HRC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research - 1 month ago

Let's see if Hill-Rom Holdings (HRC) stock is a good choice for value-oriented investors right now from multiple angles.

Zacks Investment Research - 1 month ago

Hill-Rom (HRC) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 1 month ago

Within Front Line Care (FLC), Hill-Rom (HRC) registers growth in vital signs monitoring, blood pressure and thermometry as well as the completion of the U.S. stockpile order for noninvasive ve...

Forbes - 1 month ago

We believe that Hill-Rom Holdings stock (NYSE: HRC), best known for its hospital beds and patient mobility solutions, may be a good buying opportunity at the present time. HRC stock trades nea...

Seeking Alpha - 1 month ago

Hill-Rom Holdings has enjoyed a strong 2H 2020, with sequential growth across quarters, and a mild recovery from Covid-related headwinds. Moderate stability in bed demand, strength in internat...

PRNewsWire - 2 months ago

CHICAGO, Nov. 17, 2020 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that it will present at the 3rd Annual Evercore ISI HealthCONx Virtual Conference on Tuesday, December 1, 2020. John ...

Zacks Investment Research - 2 months ago

In Q3, Hill-Rom's (HRC) bed orders and backlog in the United States accelerates with sequential recovery in Patient Support Systems arm.

Seeking Alpha - 2 months ago

Hill-Rom Holdings, Inc. (HRC) CEO John Groetelaars on Q4 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Hill-Rom (HRC) delivered earnings and revenue surprises of 8.33% and 1.15%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

PRNewsWire - 2 months ago

CHICAGO, Nov. 6, 2020 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced financial results for its fiscal fourth quarter and full year ended September 30, 2020, and provided financial guidanc...

Zacks Investment Research - 2 months ago

Several medical product stocks have come up with bullish earnings reports so far this reporting cycle. Let's see how ZBH, HRC and HMS are poised ahead of their announcements.

Other stocks mentioned: HMSY, ZBH
Zacks Investment Research - 2 months ago

Hill-Rom (HRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Forbes - 3 months ago

Hill-Rom Holdings stock gained around 10% over the month to levels of around $90 currently. But will the company's stock see higher prices over the coming weeks, or is a decline in the stock i...

PRNewsWire - 3 months ago

CHICAGO, Oct. 8, 2020 /PRNewswire/ -- Hillrom (NYSE: HRC) will host its fiscal fourth quarter 2020 earnings conference call and webcast on Friday, November 6, 2020, beginning at 7:00 a.m. (CT)...

Zacks Investment Research - 3 months ago

Investors continue to be optimistic about Hill-Rom (HRC) on product launches as well as solid third-quarter of fiscal 2020 results.

Seeking Alpha - 3 months ago

Hillrom got a boost from COVID-19-driven demand for beds and monitoring equipment, but that tailwind has faded and now the company is more exposed to near-term capex weakness.

PRNewsWire - 4 months ago

CHICAGO, Sept. 1, 2020 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that it will present at the virtual 18th Annual Morgan Stanley Global Healthcare Conference on Monday, September 14, ...

Zacks Investment Research - 4 months ago

Hill-Rom (HRC) reported earnings 30 days ago. What's next for the stock?

Forbes - 5 months ago

Investors have their eyes on the pandemic stimulus this week as congress deliberates. The U.S. jobs report is expected on Friday for July and is another indicator that will be watched closely.

Other stocks mentioned: HUM, KFY, TRS, USM
Zacks Investment Research - 5 months ago

Hill-Rom (HRC) benefits from increased demand for critical care products due to the coronavirus outbreak.

Seeking Alpha - 5 months ago

Hill-Rom Holdings' (HRC) CEO John Groetelaars on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Hill-Rom (HRC) delivered earnings and revenue surprises of 35.42% and 3.97%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

PRNewsWire - 5 months ago

CHICAGO, July 31, 2020 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced financial results for its fiscal third quarter ended June 30, 2020 and provided commentary on current business trends...

Benzinga - 5 months ago

Hill-Rom Holdings (NYSE: HRC) announces its next round of earnings this Friday, July 31.

Zacks Investment Research - 5 months ago

Hill-Rom (HRC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 5 months ago

Hill-Rom (HRC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 6 months ago

Hill-Rom (HRC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research - 6 months ago

Medical Products Industry's Near-Term Outlook Lacks Spark

Other stocks mentioned: ABT, BAX, BSX, ISRG, MDT, PRGO, RMD, SYK, ZBH
PRNewsWire - 7 months ago

CHICAGO, June 16, 2020 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced the launch of the Hillrom™ Extended Care Solution, a new, connected remote vital signs monitoring device that allows ...

Zacks Investment Research - 8 months ago

Hill-Rom (HRC) could produce exceptional returns because of its solid growth attributes.

Zacks Investment Research - 8 months ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 8 months ago

HRC vs. ABT: Which Stock Is the Better Value Option?

Other stocks mentioned: ABT
Zacks Investment Research - 8 months ago

Hill-Rom (HRC) benefits from increased product demand due to the coronavirus outbreak.

Seeking Alpha - 8 months ago

Hill-Rom Holdings, Inc. (NYSE:HRC) Q1 2020 Results Conference Call May 1, 2020 8:30 AM ET

Zacks Investment Research - 8 months ago

Hill-Rom (HRC) delivered earnings and revenue surprises of 12.28% and 3.26%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 8 months ago

  Shares of Hill-Rom Holdings (NYSE:HRC) rose 0.7% in pre-market trading after the company reported Q2 results.

InvestorPlace - 8 months ago

Aging seniors have been put firmly in the crosshairs of the novel coronavirus. These 10 stocks to buy will benefit from this brutal reality.

Other stocks mentioned: ACAD, AMED, BIIB, BYD, RCL, TDOC, THO, UNH, VTR
Zacks Investment Research - 8 months ago

Hill-Rom (HRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 9 months ago

Hill-Rom (HRC) plans to roll out five-six new products each year through 2022.

Seeking Alpha - 9 months ago

Masimo And Hill-Rom: 2 Safe Medical Device Picks To Buy During This Bear Market

Other stocks mentioned: MASI
Forbes - 9 months ago

Trump—amid criticism from both sides—has thus far only used the act sparingly.

Other stocks mentioned: GE, GM, MDT, MMM, RMD
TechCrunch - 9 months ago

With national stockpile inventory of life-saving healthcare equipment getting dangerously close to zero, President Trump signaled that he will leverage a key national security provision to ord...

Other stocks mentioned: GE, MDT, RMD
Zacks Investment Research - 9 months ago

HRC vs. ABT: Which Stock Is the Better Value Option?

Other stocks mentioned: ABT
Zacks Investment Research - 9 months ago

Investors continue to be optimistic about Hill-Rom (HRC) on its strong domestic and international results in the first quarter of fiscal 2020.

About HRC

Hill-Rom Holdings operates as a medical technology company worldwide. It operates through Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, patient mobility solutions, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and d... [Read more...]

Industry
Medical Instruments & Supplies
Founded
1969
CEO
John Groetelaars
Employees
10,000
Stock Exchange
NYSE
Ticker Symbol
HRC
Full Company Profile

Financial Performance

In 2020, HRC's revenue was $2.88 billion, a decrease of -0.90% compared to the previous year's $2.91 billion. Earnings were $223.00 million, an increase of 46.52%.

Financial Statements

Analyst Forecasts

According to 8 analysts, the average rating for HRC stock is "Buy." The 12-month stock price forecast is 115.33, which is an increase of 15.97% from the latest price.

Price Target
$115.33
(15.97% upside)
Analyst Consensus: Buy